{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:55:32Z","timestamp":1793778932756,"version":"4.6.1"},"reference-count":40,"publisher":"American Society of Hematology","issue":"9","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,14]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Epstein-Barr virus (EBV)-positive (EBV+) nodal T- and natural killer (NK)-cell lymphoma is a peripheral T-cell lymphoma (EBV+ nPTCL) that presents as a primary nodal disease with T-cell phenotype and EBV-harboring tumor cells. To date, the genetic aspect of EBV+ nPTCL has not been fully investigated. In this study, whole-exome and\/or whole-genome sequencing was performed on 22 cases of EBV+ nPTCL. TET2 (68%) and DNMT3A (32%) were observed to be the most frequently mutated genes whose presence was associated with poor overall survival (P\u00a0= .004). The RHOA p.Gly17Val mutation was identified in 2 patients who had TET2 and\/or DNMT3A mutations. In 4 patients with TET2\/DNMT3A alterations, blood cell\u2013rich tissues (the bone marrow [BM] or spleen) were available as paired normal samples. Of 4 cases, 3 had at least 1 identical TET2\/DNMT3A mutation in the BM or spleen. Additionally, the whole part of the EBV genome was sequenced and structural variations (SVs) were found frequent among the EBV genomes (63%). The most frequently identified type of SV was deletion. In 1 patient, 4 pieces of human chromosome 9, including programmed death-ligand 1 gene (PD-L1) were identified to be tandemly incorporated into the EBV genome. The 3\u2032 untranslated region of PD-L1 was truncated, causing a high-level of PD-L1 protein expression. Overall, the frequent TET2 and DNMT3A mutations in EBV+ nPTCL seem to be closely associated with clonal hematopoiesis and, together with the EBV genome deletions, may contribute to the pathogenesis of this intractable lymphoma.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012019","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T02:22:35Z","timestamp":1709346155000},"page":"2138-2147","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":19,"title":["EBV+ nodal T\/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-3691","authenticated-orcid":false,"given":"Seiichi","family":"Kato","sequence":"first","affiliation":[{"name":"1Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan"},{"name":"2Center for Clinical Pathology, Fujita Health University Hospital, Toyoake, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2473-3730","authenticated-orcid":false,"given":"Motoharu","family":"Hamada","sequence":"additional","affiliation":[{"name":"3Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9607-8536","authenticated-orcid":false,"given":"Akinao","family":"Okamoto","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamashita","sequence":"additional","affiliation":[{"name":"5Department of Pathology, Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2356-3725","authenticated-orcid":false,"given":"Hiroaki","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"6Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Arai","sequence":"additional","affiliation":[{"name":"3Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Satou","sequence":"additional","affiliation":[{"name":"7Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Gion","sequence":"additional","affiliation":[{"name":"8Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan"},{"name":"9Department of Medical Technology, Faculty of Health Sciences, Ehime Prefectural University of Health Sciences, Iyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5234-6861","authenticated-orcid":false,"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"8Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan"},{"name":"10Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Tsuyuki","sequence":"additional","affiliation":[{"name":"2Center for Clinical Pathology, Fujita Health University Hospital, Toyoake, Japan"},{"name":"11Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Miyata-Takata","sequence":"additional","affiliation":[{"name":"12Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Takata","sequence":"additional","affiliation":[{"name":"12Division of Molecular and Cellular Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Asano","sequence":"additional","affiliation":[{"name":"13Department of Clinical Laboratory, Nagano Prefectural Suzaka Hospital, Suzaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8284-567X","authenticated-orcid":false,"given":"Emiko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"7Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"6Department of Pathology, School of Medicine, Kurume University, Kurume, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-1399","authenticated-orcid":false,"given":"Akihiro","family":"Tomita","sequence":"additional","affiliation":[{"name":"4Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waki","family":"Hosoda","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[{"name":"11Department of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3139-9272","authenticated-orcid":false,"given":"Yusuke","family":"Okuno","sequence":"additional","affiliation":[{"name":"3Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,4,28]]},"reference":[{"issue":"4","key":"2024051415212818200_bib1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr Virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2024051415212818200_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"issue":"2","key":"2024051415212818200_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"2024051415212818200_bib4","author":"Swerdlow","year":"2017"},{"issue":"11","key":"2024051415212818200_bib5","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"2024051415212818200_bib6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"8","key":"2024051415212818200_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3324\/haematol.2021.280003","article-title":"Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T\/NK-cell lymphoma from ENKTL and PTCL-NOS","volume":"107","author":"Wai","year":"2022","journal-title":"Haematologica"},{"issue":"8","key":"2024051415212818200_bib8","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/cas.13652","article-title":"Reappraisal of nodal Epstein-Barr Virus-negative cytotoxic T-cell lymphoma: Identification of indolent CD5+ diseases","volume":"109","author":"Yamashita","year":"2018","journal-title":"Cancer Sci"},{"issue":"8","key":"2024051415212818200_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/pin.12950","article-title":"PD-L1 expression on tumor or stromal cells of nodal cytotoxic T-cell lymphoma: a clinicopathological study of 50 cases","volume":"70","author":"Yamashita","year":"2020","journal-title":"Pathol Int"},{"issue":"14","key":"2024051415212818200_bib10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","article-title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","volume":"131","author":"Murakami","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2024051415212818200_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","article-title":"VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing","volume":"22","author":"Koboldt","year":"2012","journal-title":"Genome Res"},{"issue":"3","key":"2024051415212818200_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein\u2013Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"issue":"12","key":"2024051415212818200_bib13","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1002\/cam4.1875","article-title":"Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells","volume":"7","author":"Ishikawa","year":"2018","journal-title":"Cancer Med"},{"issue":"12","key":"2024051415212818200_bib14","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"26","key":"2024051415212818200_bib15","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"2024051415212818200_bib16","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"2024051415212818200_bib17","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"10","key":"2024051415212818200_bib18","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1111\/cas.15094","article-title":"Clonal hematopoiesis and associated diseases: a review of recent findings","volume":"112","author":"Asada","year":"2021","journal-title":"Cancer Sci"},{"issue":"2","key":"2024051415212818200_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"2024051415212818200_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1182\/blood-2013-10-531509","article-title":"A\u00a0targeted mutational landscape of angioimmunoblastic T-cell lymphoma","volume":"123","author":"Odejide","year":"2014","journal-title":"Blood"},{"issue":"15","key":"2024051415212818200_bib21","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"3","key":"2024051415212818200_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00428-023-03616-4","article-title":"Cytotoxic peripheral T-cell lymphomas and EBV-positive T\/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP\/SH lymphoma workshop","volume":"483","author":"Climent","year":"2023","journal-title":"Virchows Arch"},{"issue":"25","key":"2024051415212818200_bib23","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","article-title":"DNMT3A mutations in acute myeloid leukemia","volume":"363","author":"Ley","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"2024051415212818200_bib24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41379-019-0415-5","article-title":"Mutational profile and EBV strains of extranodal NK\/T-cell lymphoma, nasal type in Latin America","volume":"33","author":"Montes-Mojarro","year":"2020","journal-title":"Mod Pathol"},{"issue":"12","key":"2024051415212818200_bib25","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3390\/cancers14122899","article-title":"Epstein-Barr virus (EBV) is mostly latent and clonal in angioimmunoblastic T cell lymphoma (AITL)","volume":"14","author":"Bahri","year":"2022","journal-title":"Cancers"},{"issue":"10","key":"2024051415212818200_bib26","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41375-020-0990-y","article-title":"Advances in understanding of angioimmunoblastic T-cell lymphoma","volume":"34","author":"Chiba","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"2024051415212818200_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13148-022-01395-4","article-title":"Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas","volume":"14","author":"de P\u00e1dua Covas Lage","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"1","key":"2024051415212818200_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/his.14919","article-title":"A\u00a0nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype","volume":"83","author":"Zhang","year":"2023","journal-title":"Histopathology"},{"issue":"9","key":"2024051415212818200_bib29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/PAS.0b013e3181ec577a","article-title":"Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone","volume":"34","author":"Langer","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2024051415212818200_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"issue":"1","key":"2024051415212818200_bib31","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"2024051415212818200_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"2024051415212818200_bib33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.3358","article-title":"Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma","volume":"47","author":"Jiang","year":"2015","journal-title":"Nat Genet"},{"issue":"19","key":"2024051415212818200_bib34","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"2024051415212818200_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/bloodadvances.2022007541","article-title":"Genetic and immunohistochemical profiling of NK\/T-cell lymphomas reveals prognostically relevant BCOR-MYC association","volume":"7","author":"Oishi","year":"2023","journal-title":"Blood Adv"},{"issue":"12","key":"2024051415212818200_bib36","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"issue":"10","key":"2024051415212818200_bib37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1080\/15384047.2019.1638670","article-title":"Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disorders","volume":"20","author":"Gao","year":"2019","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2024051415212818200_bib38","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"},{"issue":"8","key":"2024051415212818200_bib39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s41379-022-01022-w","article-title":"Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations","volume":"35","author":"Nicolae","year":"2022","journal-title":"Mod Pathol"},{"issue":"2","key":"2024051415212818200_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.immuni.2017.07.020","article-title":"The DNA methylcytosine dioxygenase Tet2 sustains immunosuppressive function of tumor-infiltrating myeloid cells to promote melanoma progression","volume":"47","author":"Pan","year":"2017","journal-title":"Immunity"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/9\/2138\/2224967\/blooda_adv-2023-012019-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/9\/2138\/2224967\/blooda_adv-2023-012019-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:22:22Z","timestamp":1715700142000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/9\/2138\/515170\/EBV-nodal-T-NK-cell-lymphoma-associated-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,28]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012019","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,28]]}}}